PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/PRIVATE BETA — FOUNDER ACCESS ONLY/INVESTORS PERMANENTLY EXCLUDED/VERIFIED FOUNDERS ONLY/
Fund Intelligence

VC Fund Dossiers

1980 funds indexed — verified founder intel only

1980
Funds
Verified
Access
0 allowed
Investors
23 of 1980 fundsClear Filters
Status
Fund Name
HQ
Stage Focus
Truth Cards
AI INTEL
AbbVie Ventures
North Chicago, IL
Multi-stage
0No verified founder data yet
BERNIE'S TAKE

AbbVie Ventures is the corporate VC arm that actually gets it - they move fast for a pharma giant and their checks are meaningful. The team has real scientific chops and can open doors at AbbVie proper, which matters when you need partnership or acquisition conversations. That said, they're not leading rounds and their investment committee can get spooked by anything too far outside AbbVie's wheelhouse. If your biotech aligns with their therapeutic areas, they're gold. If not, don't waste time - they stick to their knitting religiously.

AI INTEL
Andreessen Horowitz Bio + Health
Menlo Park, CA
Multi-stage
0No verified founder data yet
BERNIE'S TAKE

A16z Bio brings serious firepower and deep pockets, but you're getting the full Andreessen treatment - meaning lots of platform resources but also high expectations and board oversight. They're genuinely helpful on business model design and scaling challenges, especially if you're building something that intersects tech and bio. The partners actually know healthcare, which is rarer than you'd think. Downside: they're not afraid to bring in new management if things go sideways, and their brand attracts competitor attention early.

AI INTEL
B Capital Group
Manhattan Beach, CA
Multi-stage
0No verified founder data yet
BERNIE'S TAKE

B Capital is basically BCG's VC arm with Facebook money backing it. The BCG connection is their real differentiator - they can actually open enterprise doors that most VCs can't. Raj Ganguly is the operational heavy lifter while Eduardo provides the Silicon Valley credibility. They're genuinely helpful on sales strategy and international expansion, especially into Southeast Asia. The downside? They can be pretty hands-on and expect you to leverage their consulting network, which isn't for every founder. Also, their enterprise focus means consumer startups might feel like second-class citizens.

AI INTEL
Cathay Innovation
Paris
Multi-stage
0No verified founder data yet
BERNIE'S TAKE

Cathay Innovation is genuinely useful if you're serious about Asia expansion, but don't expect them to be your primary US growth driver. Their China network is real and valuable - they've actually helped portfolio companies navigate regulatory complexity and find local partnerships that matter. The partners know their stuff operationally, but they're not the flashiest brand name for Silicon Valley credibility. They write reasonable check sizes for European growth stage but can be slow to decision-making due to cross-border coordination. If Asia is core to your strategy, they're worth the conversation. If it's just nice-to-have, there are faster, more focused options.

AI INTEL
Euclidean Capital
New York, NY
Multi-stage
0No verified founder data yet
BERNIE'S TAKE

This isn't your typical family office - it's Renaissance Technologies with a venture capital arm. Euclidean Capital serves as a family office of James Simons who is a hedge fund manager, mathematician, and founder of Renaissance Technologies. The stocks represent just a small part of Euclidean's portfolio - most are 'residuals' from VC investments they held onto after IPO. They're essentially doing quantitative venture capital before anyone called it that. The team is small but incredibly sophisticated - Chhabra pioneered goals-based wealth management and Miller has deep quant experience. They write big checks ($50M+ rounds) and focus on math-heavy sectors where their analytical edge matters most. Don't expect warm fuzzy founder support - this is clinical, data-driven capital.

AI INTEL
F-Prime Capital
Cambridge, MA
Multi-stage
0No verified founder data yet
BERNIE'S TAKE

F-Prime is what happens when you take Fidelity's $2 trillion checkbook and 50+ years of VC experience and point it at early-stage companies - they're one of the few funds that actually creates companies from scratch (30+ times) rather than just writing checks to existing startups. "I have seen the F-Prime team at work from the perspective of a founder and as a venture partner," Eric told us. "They have a massive wealth of knowledge and supportive resources at their disposal. If they aren't able to help portfolio companies with a problem, they almost certainly know someone who can — and they're always happy to make the introduction." The "technical-risk-yes, regulatory-risk-no" filter is smart - they'll back CRISPR but avoid antibiotics. Their healthcare track record is legitimately impressive (Toast, Flywire, Beam, Denali), and having no external LPs means they can be patient capital when others are panicking. Stephen Knight has been there 20+ years and knows what he's doing.

LISTED
General Catalyst Health
San Francisco, CA
Multi-stage
0Be the first to add intel
LISTED
GV Life Sciences
Mountain View, CA
Multi-stage
0Be the first to add intel
LISTED
Horizon Ventures
Hong Kong
Multi-stage
0Be the first to add intel
LISTED
Insight Partners
New York, NY
Multi-stage
0Be the first to add intel
LISTED
Johnson & Johnson Innovation
New Brunswick, NJ
Multi-stage
0Be the first to add intel
LISTED
Lightspeed Venture Partners
Menlo Park, CA
Multi-stage
0Be the first to add intel
LISTED
Lightspeed Venture Partners
Menlo Park, CA
Multi-stage
0Be the first to add intel
LISTED
Main Sequence Ventures
Sydney, NSW
Multi-stage
0Be the first to add intel
LISTED
Mubadala Ventures
Abu Dhabi
Multi-stage
0Be the first to add intel
LISTED
Norwest Venture Partners Enterprise
Menlo Park, CA
Multi-stage
0Be the first to add intel
LISTED
Novartis Venture Fund
Basel
Multi-stage
0Be the first to add intel
LISTED
Omega Funds
Boston, MA
Multi-stage
0Be the first to add intel
LISTED
OrbiMed
New York, NY
Multi-stage
0Be the first to add intel
LISTED
Pfizer Ventures
New York, NY
Multi-stage
0Be the first to add intel
LISTED
Roche Venture Fund
Basel
Multi-stage
0Be the first to add intel
LISTED
Thiel Capital
West Hollywood, CA
Multi-stage
0Be the first to add intel
LISTED
Versant Ventures
San Francisco, CA
Multi-stage
0Be the first to add intel
23 RECORDS — INVESTOR ACCESS PERMANENTLY DENIED
BERNBOOK // FUND INTEL v1